Literature DB >> 17213706

Establishment and biological characterization of canine histiocytic sarcoma cell lines.

Daigo Azakami1, Makoto Bonkobara, Tsukimi Washizu, Akiko Iida, Mari Kondo, Rina Kato, Yumiko Niikura, Shuko Iwaki, Satoshi Tamahara, Naoaki Matsuki, Kenichiro Ono.   

Abstract

Seven novel cell lines from canine histiocytic sarcoma (HS), three of which were disseminated cutaneous HS and four of which were synovial HS, were established. All of the established cell lines had the same morphological (by light and electron microscopic findings), cytochemical (alpha-naphthyl butyrate esterase-positive), and immunohistochemical (vimentin- and lysozyme-positive, and cyto-keratin-negative) characteristics as the original HS tumor cells. All of the established cell lines injected into nude mice subcutaneously produced solid tumors. Because the established cell lines also showed phagocytic and processing activities, the HS tumor cells appear to originate from the mononuclear phagocytic system cells, despite their differences in locations or organs.

Entities:  

Mesh:

Year:  2006        PMID: 17213706     DOI: 10.1292/jvms.68.1343

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  7 in total

1.  Development of an Orthotopic Intrasplenic Xenograft Mouse Model of Canine Histiocytic Sarcoma and Its Use in Evaluating the Efficacy of Treatment with Dasatinib.

Authors:  Marilia Takada; Lauren A Smyth; Jeremy Ml Hix; Sarah M Corner; Matti Kiupel; Vilma Yuzbasiyan-Gurkan
Journal:  Comp Med       Date:  2019-02-04       Impact factor: 0.982

2.  Evaluation of the drug sensitivity and expression of 16 drug resistance-related genes in canine histiocytic sarcoma cell lines.

Authors:  Hajime Asada; Hirotaka Tomiyasu; Yuko Goto-Koshino; Yasuhito Fujino; Koichi Ohno; Hajime Tsujimoto
Journal:  J Vet Med Sci       Date:  2015-02-21       Impact factor: 1.267

3.  Molecular cloning and gene expression of canine apoptosis inhibitor of macrophage.

Authors:  Shintaro Tomura; Mona Uchida; Tomohiro Yonezawa; Masato Kobayashi; Makoto Bonkobara; Satoko Arai; Toru Miyazaki; Satoshi Tamahara; Naoaki Matsuki
Journal:  J Vet Med Sci       Date:  2014-09-01       Impact factor: 1.267

4.  Apoptosis inhibitor of macrophage (AIM) reduces cell number in canine histiocytic sarcoma cell lines.

Authors:  Mona Uchida; Kohei Saeki; Shingo Maeda; Satoshi Tamahara; Tomohiro Yonezawa; Naoaki Matsuki
Journal:  J Vet Med Sci       Date:  2016-05-30       Impact factor: 1.267

5.  A novel canine histiocytic sarcoma cell line: initial characterization and utilization for drug screening studies.

Authors:  Marilia Takada; Maciej Parys; Emmalena Gregory-Bryson; Paulo Vilar Saavedra; Matti Kiupel; Vilma Yuzbasiyan-Gurkan
Journal:  BMC Cancer       Date:  2018-03-01       Impact factor: 4.430

6.  Antitumor activity of the dual PI3K/mTOR inhibitor gedatolisib and the involvement of ABCB1 in gedatolisib resistance in canine tumor cells.

Authors:  Yusuke Murase; Kenji Hosoya; Takachika Sato; Sangho Kim; Masahiro Okumura
Journal:  Oncol Rep       Date:  2022-01-28       Impact factor: 3.906

7.  Inhibition of survivin influences the biological activities of canine histiocytic sarcoma cell lines.

Authors:  Hiroki Yamazaki; Satoshi Takagi; Yuki Hoshino; Kenji Hosoya; Masahiro Okumura
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.